Polio

Recent News

Nov 17, 2017

News Scan for Nov 17, 2017

Saudi MERS case
Polio in Afghanistan
Tainted tiny turtles
Pandemic planning guide
US flu rises
Nov 10, 2017

News Scan for Nov 10, 2017

Madagascar plague totals
Polio in Syria
Nov 03, 2017

News Scan for Nov 03, 2017

Variant flu cases
Livestock-related MRSA
More polio cases
Zika in pregnant women
Oct 31, 2017

News Scan for Oct 31, 2017

H5N8 in South Africa
Puppy-linked Campylobacter
Polio in Afghanistan
Ebola deaths in seniors
Global hepatitis progress
Oct 20, 2017

News Scan for Oct 20, 2017

Marburg virus in Uganda
Polio in Afghanistan and Syria
Salmonella outbreak probe ends
Tdap coverage in pregnancy
Oct 13, 2017

News Scan for Oct 13, 2017

Vaccine attack in Syria
El Nino and Zika
Detecting congenital Zika
MDR pneumonia
Oct 06, 2017

News Scan for Oct 06, 2017

Polio in Syria
Plague in Madagascar
More Cyclospora
Antimicrobial use in Danish animals
Sep 29, 2017

News Scan for Sep 29, 2017

Pandemic flu vaccine strains
Ebola vaccine support
More Cyclospora
Promising typhoid vaccine
Plague in Madagascar
Pakistan polio
Sep 22, 2017

News Scan for Sep 22, 2017

MERS in UAE
Vaccine-related polio
More chikungunya in France, Italy
Waning flu vaccine protection
H5N8 in South Africa
Sep 07, 2017

News Scan for Sep 07, 2017

Saudi MERS case
Zika retina damage
VHF PPE profile
Yellow fever in Brazil
Pakistani polio case

Resources & Literature

Recent Literature

Bahl S, Hampton LM, Bhatnagar P, et al. Detection of Sabin-like type 2 poliovirus from sewage after global cessation of trivalent oral poliovirus vaccine — Hyderabad and Ahmedabad, India, August-September 2016. (Notes from the field) MMWR 2017 Jan 6;65(52):1493-4

Benn CS, Jacobsen LH, Fisker AB, et al. Campaigns with oral polio vaccine may lower mortality and create unexpected results. Vaccine 2017 (published online Jan 27)

Berchenko Y, Manor Y, Freedman LS, et al. Estimation of polio infection prevalence from environmental surveillance data. Sci Transl Med 2017 Mar 29;9(383):eaaf6786

Collett MS, Hincks JR, Benschop K, et al. Antiviral activity of pocapavir in a randomized, blinded, placebo-controlled human oral poliovirus vaccine challenge model. J Infect Dis 2016 (published online Dec 8)

Diop OM, Asghar H, Gavrilin E, et al. Virologic monitoring of poliovirus type 2 after oral poliovirus vaccine type 2 withdrawal in April 2016 — worldwide, 2016-2017. MMWR 2017 May 26;66(20):538-42

Duizer E, Ruijs WL, van der Weijden CP, et al. Response to a wild poliovirus type 2 (WPV2)-shedding event following accidental exposure to WPV2, the Netherlands, April 2017. Euro Surveill 2017 May 25;22(21):pii=30542

Hsu CH, Mahamud A, Safdar RM, et al. Progress toward poliomyelitis eradication — Pakistan, January 2015-September 2016. MMWR 2016 Nov 25;65(46):1295-9

Hussain I, Mach O, Habib A, et al. Seroprevalence of anti-polio antibodies in children from polio high-risk areas of Pakistan: a cross-sectional survey 2015-2016. Pediatr Infect Dis J 2017 Sep;36(9):e230-6

John J, Giri S, Karthikeyan AS, et al. The duration of intestinal immunity after an inactivated poliovirus vaccine booster dose in children immunized with oral vaccine: a randomised controlled trial. J Infect Dis 2016 (published online Dec 21)

Jorba J, Diop OM, Iber J, et al. Update on vaccine-derived polioviruses — worldwide, January 2016-June 2017. MMWR 2017 Nov 3;66(43):1185-91

Maes EF, Diop OM, Jorba J, et al. Surveillance systems to track progress toward polio eradication — worldwide, 2014-2016. MMWR Apr 7;66(13):359-65

Marin M, Patel M, Oberste S, et al. Guidance for assessment of poliovirus vaccination status and vaccination of children who have received poliovirus vaccine outside the United States. MMWR 2017 Jan 13;66(01):23-5

Martinez M, Shukla H, Nikulin J, et al. Progress toward poliomyelitis eradication — Afghanistan, January 2016-June 2017. MMWR 2017 Aug 18;66(32):854-8

Mbaeyi C, Ryan MJ, Smith P, et al. Response to a large polio outbreak in a setting of conflict Middle East, 2013-2015. MMWR 2017 Mar 3;66(8):227-31

Mohanty MC, Madkaikar MR, Desai M, et al. Poliovirus excretion in children with primary immunodeficiency disorders, India. Emerg Infect Dis 2017 (published online Aug 28)

Nnadi C, Damisa E, Esapa L, et al. Continued endemic wild poliovirus transmission in security-compromised areas — Nigeria, 2016. MMWR 2017 Feb 24;66(7):190-3

Previsani N, Singh H, St. Pierre J, et al. Progress toward containment of poliovirus type 2 worldwide, 2017. MMWR 2017 Jun 23;66(24):649-52

Rivera L, Pedersen RS, Pena L, et al. Immunogenicity and safety of three aluminum hydroxide adjuvanted vaccines with reduced doses of inactivated polio vaccine (IPV-Al) compared with standard IPV in young infants in the Dominican Republic: a phase 2, non-inferiority, observer-blinded, randomised, and controlled dose investigation trial. Lancet Infect Dis 2017 (published online Apr 25)

Shirreff G, Wadood MZ, Vaz RG, et al. Estimated effect of inactivated poliovirus vaccine campaigns, Nigeria and Pakistan, January 2014-April 2016. Emerg Infect Dis 2016 (published online Nov 18)

Tanluchi M, Famulare M, Zaman K, et al. Community transmission of type 2 poliovirus after cessation of trivalent oral polio vaccine in Bangladesh: an open-label cluster-randomised trial and modelling study. Lancet Infect Dis 2017 (published online Jul 7)

Weil M, Shulman LM, Heiman S, et al. Prolonged excretion of type-2 poliovirus from a primary immune deficient patient during the transition to a type-2 poliovirus-free world, Israel, 2016. Euro Surveill 2016 Nov 24;21(47):pii=30408

Newsletter Sign-up

Get CIDRAP news and other free newsletters.

Sign up now»

OUR UNDERWRITERS

Unrestricted financial support provided by

Bentson Foundation 3MGilead Become an underwriter»